Braxlosiran
Braxlosiran is a small nucleic acid that targets DUX4 (double homeobox protein) and can be used to synthesize AOC drugs, such as Delpacibart braxlosiran. Abnormal expression of the DUX4 protein leads to changes in gene expression in muscle cells, and these changes are associated with the loss of muscle function in facioscapulohumeral muscular dystrophy (FSHD).
Product Specifications
UNSPSC
12352208
Target
Antibody-Oligonucleotide Conjugates (AOCs)
Related Pathways
Antibody-drug Conjugate/ADC Related
Field of Research
Inflammation/Immunology
Smiles
[Braxlosiran]
References & Citations
[1]Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use. WO2025177244A1
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041003-100 1x 100 µL
Mucin 5AC (MUC5AC) (58M1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741187-100 1x 100 µL
PAX7 (PAX7/1187), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471621-100 1x 100 µL
Endoglin / CD105 (ENG/1621), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680419-500 1x 500 µL
Transglutaminase II (TGM2/419), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details